Current immunosuppressive agents: efficacy, side effects, and utilization

This publication has 70 references indexed in Scilit:

• TRANSPLANT 2001: The Joint American Transplant Meeting
  American Journal of Transplantation, 2001
• Impact of Absorption Profiling on Efficacy and Safety of Cyclosporin Therapy in Transplant Recipients
  Clinical Pharmacokinetics, 2000
• CAMPATH IH ALLOWS LOW-DOSE CYCLOSPORINE MONOTHERAPY IN 31 CADAVERIC RENAL ALLOGRAFT RECIPIENTS
  Transplantation, 1999
• THE LONG-TERM USE OF MYCOPHENOLATE MOFETIL IN PEDIATRIC RENAL TRANSPLANTATION. A REPORT OF THE PEDIATRIC MYCOPHENOLATE MOFETIL STUDY GROUP (PMMSG)
  Transplantation, 1999
• Abbreviated Pharmacokinetic Profiles in Area-Under-the-Curve Monitoring of Cyclosporine Therapy in De Novo Renal Transplant Patients Treated with Sandimmune or Neoral
  Therapeutic Drug Monitoring, 1999
• Mycophenolate mofetil – is it worth the cost? The in‐favor opinion
  Pediatric Transplantation, 1999
• HUMANIZED MONOCLONAL ANTI INTERLEUKIN-2 RECEPTOR (IL-2R) ANTIBODY DACLIZUMAB (ZENAPAX??) IN PEDIATRIC (Ped) RENAL TRANSPLANTATION (Tx)
  Transplantation, 1998
• Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients
  The Lancet, 1997
• CD40 and Its Ligand in Host Defense
  Immunity, 1996
• The immunosuppressive and toxic effects of FK-506 are mechanistically related: pharmacology of a novel antagonist of FK-506 and rapamycin.
  The Journal of Experimental Medicine, 1992